Page last updated: 2024-10-30

metformin and Osteopetrosis

metformin has been researched along with Osteopetrosis in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Osteopetrosis: Excessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis (HEMATOPOIESIS, EXTRAMEDULLARY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, Y1
Li, Y1
Xue, J1
Jia, Y1
Hu, J1

Other Studies

1 other study available for metformin and Osteopetrosis

ArticleYear
Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats.
    European journal of pharmacology, 2010, Jun-10, Volume: 635, Issue:1-3

    Topics: Absorptiometry, Photon; Animals; Biomarkers; Bone Density; Female; Gene Expression Regulation; Hypog

2010